chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Physical deconditioning, Procalcitonin, Pulmonary embolism, Pulmonary hypertension, SARS-CoV-2 test positive
Clinical narrative: 2/7/2022 PROGRESS NOTE 71 yo gentleman w/ h/o COPD, recently diagnosed right humerus fracture, tested positive for COVID-19 ~1/15/22, who was admitted to emergency department 1/26/2022 with acute hypoxemic respiratory failure due to COVID-19, Covid pneumonia and acute left lung PE   Acute hypoxic resp failure due to COVID-19 pneumonia, acute left lung PE and probable COPD exacerbation: ---   Fully vaccinated with Moderna COVID-19 vaccine (3/17/2021 and/15/21) ---   Did not received a booster shot yet ---   Tested positive for COVID-19 ~ 1/15/22 ---   CT chest pulmonary angio at admit revealed extensive bilateral GGO ---   The CT scan also revealed LLL PE ---   On steroid since admit, currently on prednisone 60 mg daily as of 2/3/22, plan for 2-week taper at discharge ---   Continue apixaban ---   D/c heparin drip at 7 pm tonight and start Eliquis ---   Not a candidate for Tocilizumab or baricitinib, presented outside window for treatment ---   Currently on 2 L NC O2 supplement at rest ---   CRP < 1.0 for more than 6 days ---   D-dimer 1.07 --- > 1.0 yesterday. ---   Procalcitonin level was 0.11, thus superimposed bacterial infection less likely ---   Hemodynamically stable. ---   Full barrier isolation discontinued ---   Wean off O2 supplement if able ---   Home O2 eval today, required 6 L with exertion unstable on his feet, recommend out of bed to chair and PT OT every day for deconditioning   Acute LLL PE: ---   Precipitated by COVID-19 infection ---   Admit bilateral extremity ultrasound negative for DVT ---   Admit CT chest pulmonary angio revealed nonocclusive LLL PE ---   TTE on 2/4/2022 revealed EF 65-70%, mild pulmonary hypertension, moderate TR, no right heart strain. ---    Continue Eliquis, plan for 3 months for provoked PE   COPD with acute exacerbation ---   Precipitated by COVID-19 pneumonia ---   On O2 supplement and steroid since admission ---   On prednisone 60 mg po daily as of 2/3/2022, 2 week taper at discharge---   Schedule albuterol inhaler ---   PTA inhalers   Hx of nocturia Urinary frequency: ---   History consistent with BPH.  ---   UTI ruled out. ---   Tamsulosin 0.4 mg po qhs, initiated 2/3/2022   Proximally minimally displaced right humerus fracture: ---   Continuing nonoperative management and immobilization with sling.  ---   The patient scheduled to follow-up with orthopedic surgery as an outpatient.   Depression:  ---   PTA fluoxetine 40 mg p.o. daily ---   PTA Effexor 150 mg p.o. daily   GERD:  ---   PTA pantoprazole 40 mg p.o. daily   Code status:   Full Code  Prophylaxis:   Heparin drip  Disposition:   PT/OT recommending TCU.    Insurance does not cover TCU, will need to discharge home with home O2, home health when medically ready, O2 requirement is too high presently with exertion
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Tricuspid valve incompetence, Ultrasound Doppler normal
Clinical narrative: 2/7/2022 PROGRESS NOTE 71 yo gentleman w/ h/o COPD, recently diagnosed right humerus fracture, tested positive for COVID-19 ~1/15/22, who was admitted to emergency department 1/26/2022 with acute hypoxemic respiratory failure due to COVID-19, Covid pneumonia and acute left lung PE   Acute hypoxic resp failure due to COVID-19 pneumonia, acute left lung PE and probable COPD exacerbation: ---   Fully vaccinated with Moderna COVID-19 vaccine (3/17/2021 and/15/21) ---   Did not received a booster shot yet ---   Tested positive for COVID-19 ~ 1/15/22 ---   CT chest pulmonary angio at admit revealed extensive bilateral GGO ---   The CT scan also revealed LLL PE ---   On steroid since admit, currently on prednisone 60 mg daily as of 2/3/22, plan for 2-week taper at discharge ---   Continue apixaban ---   D/c heparin drip at 7 pm tonight and start Eliquis ---   Not a candidate for Tocilizumab or baricitinib, presented outside window for treatment ---   Currently on 2 L NC O2 supplement at rest ---   CRP < 1.0 for more than 6 days ---   D-dimer 1.07 --- > 1.0 yesterday. ---   Procalcitonin level was 0.11, thus superimposed bacterial infection less likely ---   Hemodynamically stable. ---   Full barrier isolation discontinued ---   Wean off O2 supplement if able ---   Home O2 eval today, required 6 L with exertion unstable on his feet, recommend out of bed to chair and PT OT every day for deconditioning   Acute LLL PE: ---   Precipitated by COVID-19 infection ---   Admit bilateral extremity ultrasound negative for DVT ---   Admit CT chest pulmonary angio revealed nonocclusive LLL PE ---   TTE on 2/4/2022 revealed EF 65-70%, mild pulmonary hypertension, moderate TR, no right heart strain. ---    Continue Eliquis, plan for 3 months for provoked PE   COPD with acute exacerbation ---   Precipitated by COVID-19 pneumonia ---   On O2 supplement and steroid since admission ---   On prednisone 60 mg po daily as of 2/3/2022, 2 week taper at discharge---   Schedule albuterol inhaler ---   PTA inhalers   Hx of nocturia Urinary frequency: ---   History consistent with BPH.  ---   UTI ruled out. ---   Tamsulosin 0.4 mg po qhs, initiated 2/3/2022   Proximally minimally displaced right humerus fracture: ---   Continuing nonoperative management and immobilization with sling.  ---   The patient scheduled to follow-up with orthopedic surgery as an outpatient.   Depression:  ---   PTA fluoxetine 40 mg p.o. daily ---   PTA Effexor 150 mg p.o. daily   GERD:  ---   PTA pantoprazole 40 mg p.o. daily   Code status:   Full Code  Prophylaxis:   Heparin drip  Disposition:   PT/OT recommending TCU.    Insurance does not cover TCU, will need to discharge home with home O2, home health when medically ready, O2 requirement is too high presently with exertion
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac arrest, Chest pain, Death, Electrocardiogram, Life support
Clinical narrative: Per ED note: Briefly, 56 y.o. male w/ hx of well-controlled HIV, recent Pfizer vaccination 1 wk ago who reports to ER as a cardiac arrest. For the past several days has been c/o CP + myalgias. This AM awoke w/ CP and after getting up to ambulate to the bathroom had a witnessed collapse and bystander CPR was initiated. Total down-time + ACLS by EMS 40 min prior to arrival. PEA during the entire time. On arrival, bedside US rapidly performed showing a large pericardial effusion with thick clot and no underlying cardiac activity. Once pericardiocentesis kit obtained paused compressions for pericardiocentesis under emergent conditions/consent. Accessed the pericardial sac under US and EKG guidance and aspirated a small amount of blood but unable to aspirate remainder of clot. Given lack of underlying cardiac activity, no pulses, TOD called at 0607.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Pericardial drainage, Pericardial effusion, Pulse absent, Pulseless electrical activity
Clinical narrative: Per ED note: Briefly, 56 y.o. male w/ hx of well-controlled HIV, recent Pfizer vaccination 1 wk ago who reports to ER as a cardiac arrest. For the past several days has been c/o CP + myalgias. This AM awoke w/ CP and after getting up to ambulate to the bathroom had a witnessed collapse and bystander CPR was initiated. Total down-time + ACLS by EMS 40 min prior to arrival. PEA during the entire time. On arrival, bedside US rapidly performed showing a large pericardial effusion with thick clot and no underlying cardiac activity. Once pericardiocentesis kit obtained paused compressions for pericardiocentesis under emergent conditions/consent. Accessed the pericardial sac under US and EKG guidance and aspirated a small amount of blood but unable to aspirate remainder of clot. Given lack of underlying cardiac activity, no pulses, TOD called at 0607.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Resuscitation, Syncope, Thrombosis, Ultrasound scan abnormal
Clinical narrative: Per ED note: Briefly, 56 y.o. male w/ hx of well-controlled HIV, recent Pfizer vaccination 1 wk ago who reports to ER as a cardiac arrest. For the past several days has been c/o CP + myalgias. This AM awoke w/ CP and after getting up to ambulate to the bathroom had a witnessed collapse and bystander CPR was initiated. Total down-time + ACLS by EMS 40 min prior to arrival. PEA during the entire time. On arrival, bedside US rapidly performed showing a large pericardial effusion with thick clot and no underlying cardiac activity. Once pericardiocentesis kit obtained paused compressions for pericardiocentesis under emergent conditions/consent. Accessed the pericardial sac under US and EKG guidance and aspirated a small amount of blood but unable to aspirate remainder of clot. Given lack of underlying cardiac activity, no pulses, TOD called at 0607.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Fall, Pain in extremity, SARS-CoV-2 test positive
Clinical narrative: Patient with generalized weakness with complaints of fall couple of days ago, and right leg pain. Patient denies any nasal congestion, runny nose, chest congestion; denies any fever or chills. Patient denies any new or worsening coughs. Patient denies any chest pain. Patient denies any any nausea, vomiting, constipation or diarrhea. Initial temperature was 100°, he was admitted for monitoring due to complex chronic conditions.
Age: 48.0
Sex: M
Vaccine: HPV9
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: no adverse events or treatments.  HPV vaccine given outside of recommended age range.  Pt notified.
Sex: U
Vaccine: UNK
Symptoms: COVID-19
Clinical narrative: Pt received Covid Vaccine.  Pt admitted to the hospital with Covid related diagnosis
Age: 62.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Death
Clinical narrative: Death related to COIVD 19 infection
Sex: U
Vaccine: UNK
Symptoms: COVID-19
Clinical narrative: Pt vaccinated against Covid.  Pt admitted to the hospital with Covid related diagnosis
Age: 45.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient vaccinated against and then tested positive for COVID19.
Age: 18.0
Sex: M
Vaccine: HEP, TYP, VARCEL
Symptoms: Loss of consciousness, Syncope
Clinical narrative: SYNCOPE,  witnessed loss of consciousness no more than 30 seconds
Age: 74.0
Sex: F
Vaccine: FLU4
Symptoms: Atrial fibrillation, Cardioversion, Condition aggravated, Tachycardia
Clinical narrative: On October 7 th I developed tachicardia and extreme a fib and had to stay at hospital overnight to receive cardio conversion using intravenous Diltiazim
Age: 46.0
Sex: F
Vaccine: HPV9
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: no adverse event or treatment.  HPV vaccine give outside of recommended age range.  Pt notified.
Age: 52.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient vaccinated against and then tested positive for COVID19.
Age: 93.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Abnormal behaviour, Condition aggravated, Dementia, Fatigue
Clinical narrative: fatigue, dementia, behavior changes
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Event occurred after second vaccine; patient COVID-19 +.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Chills, Dyspnoea, Fatigue, Hyperhidrosis
Clinical narrative: Had alot of bad bad pain in right arm, Got sweats and chills. Menstrual cycle changed. Fatigued everyday. Shortness of breathe, pain in pelvic area and chest.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Menstrual disorder, Pain in extremity, Pelvic pain
Clinical narrative: Had alot of bad bad pain in right arm, Got sweats and chills. Menstrual cycle changed. Fatigued everyday. Shortness of breathe, pain in pelvic area and chest.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Dysaesthesia
Clinical narrative: Dysesthesia affecting both sides of body. ED visit to hospital admission. This visit was within 6 weeks of receiving the COVID vaccine.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Cold sweat, Cough, Fatigue, Feeling hot, Illness
Clinical narrative: Cold & hot sweats, fever, body aches less than 12 hours after the vaccination. This lasted 2 days. Since then, I have gotten my period twice monthly, I have been tired, achey. First time getting sick in 2+ years, no positive covid test, ongoing cough for 4+ weeks since 12/31.  Menstruation began again today 2/7/22 after complete 5 day cycle beginning 1/14/22.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Menstruation irregular, Pain, Pyrexia
Clinical narrative: Cold & hot sweats, fever, body aches less than 12 hours after the vaccination. This lasted 2 days. Since then, I have gotten my period twice monthly, I have been tired, achey. First time getting sick in 2+ years, no positive covid test, ongoing cough for 4+ weeks since 12/31.  Menstruation began again today 2/7/22 after complete 5 day cycle beginning 1/14/22.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Anger, Depression, Feeling abnormal, Heavy menstrual bleeding, Menstruation irregular
Clinical narrative: I got very moody/angry/depressed 2 -3 days after my vaccination (felt like I was PMS'ing, but too early for PMS).   Around June 8, my depression/anger got even worse. On June 13, I actually had suicidal thoughts which is completely abnormal for me! I got my period 2 days early (on June 14). My period was heavier than normal. After I got my period, my emotions returned to normal. Since then, my periods have been normal and my moods have been normal.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Mood altered, Suicidal ideation
Clinical narrative: I got very moody/angry/depressed 2 -3 days after my vaccination (felt like I was PMS'ing, but too early for PMS).   Around June 8, my depression/anger got even worse. On June 13, I actually had suicidal thoughts which is completely abnormal for me! I got my period 2 days early (on June 14). My period was heavier than normal. After I got my period, my emotions returned to normal. Since then, my periods have been normal and my moods have been normal.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient vaccinated against and then tested positive for COVID19
Age: 4.0
Sex: F
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Expired product administered
Clinical narrative: The patient was giving an expired vaccine on the day of  01/24/2022. Varicella  T002847 Expiration date 01/23/2022
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Breast cellulitis
Clinical narrative: Cellulitis Breast - ED visit to hospital admission. This visit was within 6 weeks of receiving the COVID vaccine.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Secretion discharge, Throat irritation, Vaccine positive rechallenge
Clinical narrative: Chronic scratchy/fuzzy throat with mucous at times
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, COVID-19 pneumonia, Condition aggravated, Cough
Clinical narrative: Very limited information provided to Health Center via Hospital.  Patient was admitted to hospital on 12/28/21 for vaccination break-thru COVID 19 with fatigue, cough, SOB, and difficulty breathing.  Diagnosis included COVID-19 pneumonia, acute respiratory failure.  Patient had provided dates that Pfizer vaccine was given (1/11/21, 2/1/21, 10/25/21), but the information was not in the system.  No Lot number information was provided.  Date of discharge was not provided.  Death certificate was obtained and noted that case had died on 2/1/22 at a long term care facility with cause of death being listed as sudden respiratory arrest, COVID-19, hypertension, and diabetes.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Diabetes mellitus, Dyspnoea, Fatigue, Hypertension
Clinical narrative: Very limited information provided to Health Center via Hospital.  Patient was admitted to hospital on 12/28/21 for vaccination break-thru COVID 19 with fatigue, cough, SOB, and difficulty breathing.  Diagnosis included COVID-19 pneumonia, acute respiratory failure.  Patient had provided dates that Pfizer vaccine was given (1/11/21, 2/1/21, 10/25/21), but the information was not in the system.  No Lot number information was provided.  Date of discharge was not provided.  Death certificate was obtained and noted that case had died on 2/1/22 at a long term care facility with cause of death being listed as sudden respiratory arrest, COVID-19, hypertension, and diabetes.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory arrest, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Very limited information provided to Health Center via Hospital.  Patient was admitted to hospital on 12/28/21 for vaccination break-thru COVID 19 with fatigue, cough, SOB, and difficulty breathing.  Diagnosis included COVID-19 pneumonia, acute respiratory failure.  Patient had provided dates that Pfizer vaccine was given (1/11/21, 2/1/21, 10/25/21), but the information was not in the system.  No Lot number information was provided.  Date of discharge was not provided.  Death certificate was obtained and noted that case had died on 2/1/22 at a long term care facility with cause of death being listed as sudden respiratory arrest, COVID-19, hypertension, and diabetes.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Pneumonia
Clinical narrative: Community acquired pneumonia of right lower lobe of lung. ED visit to hospital admission. This visit was within 6 weeks of receiving the COVID vaccine.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, Death, Dyspnoea, Fatigue
Clinical narrative: Moderna COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Moderna Vaccines on 1/25/21 and 3/1/2021. Covid + 1/25/22, Presented to ED 1/25/22 c/o SOB and fatigue. Placed on BIPAP in ED due to worsening hypoxia. Admitted for acute hypoxic and hypercapnic respiratory failure complicated by pneumonia. Treated with remdesivir, Decadron, cefepime. Patient SOB continue to worsened, and family changed status to DNR/Comfort care. Expired on 1/27/22.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoxia, Inappropriate schedule of product administration, Pneumonia, Positive airway pressure therapy, Respiratory failure
Clinical narrative: Moderna COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Moderna Vaccines on 1/25/21 and 3/1/2021. Covid + 1/25/22, Presented to ED 1/25/22 c/o SOB and fatigue. Placed on BIPAP in ED due to worsening hypoxia. Admitted for acute hypoxic and hypercapnic respiratory failure complicated by pneumonia. Treated with remdesivir, Decadron, cefepime. Patient SOB continue to worsened, and family changed status to DNR/Comfort care. Expired on 1/27/22.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Moderna COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Moderna Vaccines on 1/25/21 and 3/1/2021. Covid + 1/25/22, Presented to ED 1/25/22 c/o SOB and fatigue. Placed on BIPAP in ED due to worsening hypoxia. Admitted for acute hypoxic and hypercapnic respiratory failure complicated by pneumonia. Treated with remdesivir, Decadron, cefepime. Patient SOB continue to worsened, and family changed status to DNR/Comfort care. Expired on 1/27/22.
Age: 24.0
Sex: F
Vaccine: FLU4, HEP, HEPA, HPV9, MMR, TDAP, VARCEL
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient was given pediatric Hep A vaccine and it should of been Adult Hep A vaccine. Patient will need to return to office to receive Adult Hep A vaccine.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Diverticulitis
Clinical narrative: Diverticulitis. Hospital admission within 6 weeks of receiving the COVID vaccine.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site hypersensitivity, Pain in extremity
Clinical narrative: Sore arm. Sensitivity in arm at injection site.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Cardiac monitoring, Dizziness, Electrocardiogram, Fatigue, Pain
Clinical narrative: Almost passed out within 10 minutes of injection. Developed all symptoms of COVID-19 previously experienced. Extreme congestion, fatigue, pain and left arm sweeps 3 x it?s normal size. With a. Right red rash that looked and felt like shingles.  It lasted 12 days and was extremely painful. Random itchy rashes occur in various parts of the body. Still a persistent problem.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Rash, Rash erythematous, Rash pruritic, Respiratory tract congestion
Clinical narrative: Almost passed out within 10 minutes of injection. Developed all symptoms of COVID-19 previously experienced. Extreme congestion, fatigue, pain and left arm sweeps 3 x it?s normal size. With a. Right red rash that looked and felt like shingles.  It lasted 12 days and was extremely painful. Random itchy rashes occur in various parts of the body. Still a persistent problem.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Drug hypersensitivity, Gait disturbance, Hypoaesthesia oral, Mobility decreased
Clinical narrative: Became allergic to Advil and Aleve (numbness in entire mouth, couldn't tell if throat was closing). Previously, I would take Advil once a month over the course of a week. Developed sciatica. Woke up with intense pain 12/28/2021 in lower back. Couldn't bend over, sitting was very uncomfortable. Continued until 1/15/2022, at which point the pain became severe with no relief. Loss of mobility due to pain. Pain started to become less severe on 1/19/2022. Still have pain and mobility issues related to the pain to this day (can't walk for very long or sit/lie down in one position, bend, move certain ways), but it seems to be getting better. I was prescribed muscle relaxers for treatment but only took it once. Have been stretching and walking to treat.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Sciatica, Sleep disorder
Clinical narrative: Became allergic to Advil and Aleve (numbness in entire mouth, couldn't tell if throat was closing). Previously, I would take Advil once a month over the course of a week. Developed sciatica. Woke up with intense pain 12/28/2021 in lower back. Couldn't bend over, sitting was very uncomfortable. Continued until 1/15/2022, at which point the pain became severe with no relief. Loss of mobility due to pain. Pain started to become less severe on 1/19/2022. Still have pain and mobility issues related to the pain to this day (can't walk for very long or sit/lie down in one position, bend, move certain ways), but it seems to be getting better. I was prescribed muscle relaxers for treatment but only took it once. Have been stretching and walking to treat.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Fatigue, Headache
Clinical narrative: contracted the covid virus in November of 2021. Symptoms included sinus infection with drainage, headache, fatigue, loss of smell and taste.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Paranasal sinus hypersecretion, Sinusitis
Clinical narrative: contracted the covid virus in November of 2021. Symptoms included sinus infection with drainage, headache, fatigue, loss of smell and taste.
Age: 17.0
Sex: M
Vaccine: MENB, MNQ
Symptoms: Feeling of body temperature change, Headache, Nausea
Clinical narrative: Per mom patient complained of severe headache, feeling hot/cold, nausea
Age: 88.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Bacteraemia, COVID-19, Cardio-respiratory arrest, Death, Dyspnoea
Clinical narrative: Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 1/26/21, 2/19/21 and 9/29/2021. Covid + 1/25/22, Presented to ED 1/25/22 after HD c/o SOB and respiratory distress on 4L NC. Pt was previously admitted 12/24/21 to 1/01/22 for bacterial PNA and bacteremia. Discharged on vancomycin and cefepime, and had completed course of flagyl. Also admitted to an outside facility and d/c on 1/21/22 on IV Zosyn. Treated with cefepime and zosyn. Code Blue was called on 1/27/22 and family changed status to DNAR. Expired on 1/27/22.
Age: 88.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Haemodialysis, Inappropriate schedule of product administration, Pneumonia bacterial, Respiratory distress, SARS-CoV-2 test positive
Clinical narrative: Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 1/26/21, 2/19/21 and 9/29/2021. Covid + 1/25/22, Presented to ED 1/25/22 after HD c/o SOB and respiratory distress on 4L NC. Pt was previously admitted 12/24/21 to 1/01/22 for bacterial PNA and bacteremia. Discharged on vancomycin and cefepime, and had completed course of flagyl. Also admitted to an outside facility and d/c on 1/21/22 on IV Zosyn. Treated with cefepime and zosyn. Code Blue was called on 1/27/22 and family changed status to DNAR. Expired on 1/27/22.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Atrial fibrillation, Electrocardiogram, Hypertension, Tachycardia
Clinical narrative: A week after the 1st dose I got hypertension. I was evaluated at local Medical Center with high blood pressure and abnormal EKG. I was transported to alternate Hospital and left overnight. I was diagnosed with Tachycardia. In June I had an Ablation. In September the problems with hypertension escalated daily. I was diagnosed with Arterial Fibrillation.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Biopsy endometrium abnormal, Endometrial disorder, Endometrial hyperplasia, Endometrial thickening, Heavy menstrual bleeding
Clinical narrative: I experienced extremely heavy menstrual bleeding in the summer of 2021.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Hysterosalpingectomy, Ultrasound scan vagina abnormal
Clinical narrative: I experienced extremely heavy menstrual bleeding in the summer of 2021.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Face injury, Fall, Loss of consciousness, Nausea
Clinical narrative: Pt was instructed to remain in the waiting area for 15 min after receiving his 2nd Pfizer shot.  He chose to leave without waiting , he left the waiting area but shortly turned around and told the front desk he felt dizzy and then fainted on the floor, face first, causing a forehead laceration. Pt was sweating and was nauseated, when he woke up.  He was oriented, BP was 100/60, FSBS 88, given a bottle of water.  911 was called due to facial laceration, hitting his head from a standing position and blacking out.  Pt left on his own with the squad to go to the ER for evaluation .
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Skin laceration, Syncope
Clinical narrative: Pt was instructed to remain in the waiting area for 15 min after receiving his 2nd Pfizer shot.  He chose to leave without waiting , he left the waiting area but shortly turned around and told the front desk he felt dizzy and then fainted on the floor, face first, causing a forehead laceration. Pt was sweating and was nauseated, when he woke up.  He was oriented, BP was 100/60, FSBS 88, given a bottle of water.  911 was called due to facial laceration, hitting his head from a standing position and blacking out.  Pt left on his own with the squad to go to the ER for evaluation .
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Candida infection
Clinical narrative: I got thrust in my mouth.  It is like a yeast infection in my mouth.  It started on Oct 20th and I am still dealing with it as of today.  I went to my doctor about this.  They did a mouth sample to confirm positive for thrust.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray, Chest discomfort, Dehydration, Dyspnoea, Dyspnoea exertional
Clinical narrative: Pt was vaccinated on Thursday Feb 3rd.  Reports that on Friday Feb 4that 6am she woke up with a rapid heartrate of 154, Shortness of Breath, heaviness in chest and pain with inhalation.  She also reported that at times she could not hear well out of one ear.  Her mother contacted the primarily medical provider and was advised to go to an Emergency room for cardiac workup. Patient went to a larger area Emergency Department where she underwent multiple EKG's, 2 Chest X-Rays and lab work over several hours. She received 2 bags of fluids for dehydration prior to discharge and was advised to make an appointment with cardiologist.  Her symptoms had slightly improved but were still present on 2/5,2/6 and 2/7.  After 2/5 she reported that her heartrate would elevate into the 130s with activity, And occasionally she would have elevated heartrate with rest. She also reported that she was tired and would get short of breath with walking long distances.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Electrocardiogram, Fatigue, Heart rate increased, Hypoacusis, Laboratory test
Clinical narrative: Pt was vaccinated on Thursday Feb 3rd.  Reports that on Friday Feb 4that 6am she woke up with a rapid heartrate of 154, Shortness of Breath, heaviness in chest and pain with inhalation.  She also reported that at times she could not hear well out of one ear.  Her mother contacted the primarily medical provider and was advised to go to an Emergency room for cardiac workup. Patient went to a larger area Emergency Department where she underwent multiple EKG's, 2 Chest X-Rays and lab work over several hours. She received 2 bags of fluids for dehydration prior to discharge and was advised to make an appointment with cardiologist.  Her symptoms had slightly improved but were still present on 2/5,2/6 and 2/7.  After 2/5 she reported that her heartrate would elevate into the 130s with activity, And occasionally she would have elevated heartrate with rest. She also reported that she was tired and would get short of breath with walking long distances.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Painful respiration
Clinical narrative: Pt was vaccinated on Thursday Feb 3rd.  Reports that on Friday Feb 4that 6am she woke up with a rapid heartrate of 154, Shortness of Breath, heaviness in chest and pain with inhalation.  She also reported that at times she could not hear well out of one ear.  Her mother contacted the primarily medical provider and was advised to go to an Emergency room for cardiac workup. Patient went to a larger area Emergency Department where she underwent multiple EKG's, 2 Chest X-Rays and lab work over several hours. She received 2 bags of fluids for dehydration prior to discharge and was advised to make an appointment with cardiologist.  Her symptoms had slightly improved but were still present on 2/5,2/6 and 2/7.  After 2/5 she reported that her heartrate would elevate into the 130s with activity, And occasionally she would have elevated heartrate with rest. She also reported that she was tired and would get short of breath with walking long distances.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Patient reported having a rash on her chest. Patient received diphenhydramine 25 mg PO. At 12:12pm patient reported feeling better; symptoms unchanged. At 12:25pm patient reported feeling well; no worsening symptoms. Patient wanted to go home.
Age: 55.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Back pain, Blood test, Chest pain, Musculoskeletal chest pain, Musculoskeletal pain
Clinical narrative: Chest pains at/around the heart; back pains - left side of back, on and around shoulder blade.  Chest/back pains come and go and are particularly sharp when driving.  Walking around helps, but back and chest still feel tender to the touch.  Hurts to bend over. Hurts to bend/turn while seated. Diet doesn't seem to play a major factor. This was all after the Moderna Booster shot on 1/3/2020, NOT the J&J shot from April 2021.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Angiogram normal, Arteriogram coronary abnormal, Bipolar disorder, Blood creatinine increased, Blood pressure increased
Clinical narrative: PROGRESS NOTE 2/06/2022 38 y.o. female with no significant past cardiac history, history of hypertension, depression and chronic kidney disease.  Patient was admitted with COVID-19 infection on 1/19/2022.  Her blood pressure was markedly elevated at 220/145.  Troponin level was increased.  Echocardiogram showed reduced left ventricular systolic function with wall motion abnormality.   Reason for cardiology follow-up is newly diagnosed cardiomyopathy, wall motion abnormality and elevated troponin.   Subjective: No new symptoms   Objective:  Blood pressure 126/87, pulse 85, temperature (!) 95.7 °F (35.4 °C), resp. rate 19, height 5' 1.5" (1.562 m), weight 80 kg (176 lb 5.9 oz), SpO2 99 %, not currently breastfeeding. General: comfortable, in no acute distress.   PLAN: Hypertensive emergency H/o noncompliance. Last se een by nephrology on an outpatient HTN/ chronic kidney disease in 12/2021.  They suspect that the etiology of her chronic kidney disease could be related to hypertensive nephrosclerosis and she did have some mild proteinuria.  Given her young age, they recommended work-up and follow-up for secondary causes  Resume Coreg 25 mg p.o. twice daily, chlorthalidone 25 mg p.o. daily, hydralazine 25 mg p.o. 3 times daily, and lisinopril 40 mg p.o. daily, Held BP meds in 2/4 BP on lower side.  Held lisinopril ( Cr bumped) , Restarted Coreg 2/5 , Hydralazine PRN  24-hour urine for catecholamines and metanephrines pending Renal artery ultrasound unremarkable      Acute LLE weakness / pain  R/o CVA ,decreased motor and sensation LLE  unknown onset  Discuss with Neurology seen  MRI / MRA w./o Cer w negative  Admit CT head no acute finding  US BLE r/o  DVT  PT/ OT , nurse report patient was able to ambulate to bathroom today    Elevated troponin Likely acute myocardial injury/strain from hypertensive emergency.   Echo mildly decreased, estimated LVEF 45-50%.Inferolateral and anterolateral hypokinesis. Aspirin, Coreg.  LDL 88 ( 3/18/20)  Consulted Cardiology  ?Coronary angiogram ( Cr 1.9 )      CKD stage III  Suspected due to hypertension  Last seen by Nephrology 12/21  Cr 1.5- 1.7 for the last few years  Admit Cr 1.68 -- > Cr 1.93  Avoid nephrotoxic meds       COVID-19 Multiple constitutional symptoms  Not on O2 currently  no indication for steroids Ddimer 5.34 , US LE negative.  heparin  Supportive cares    History of seizure disorder Continue Trileptal 300mgBIDPTA ( on 600mg BID  PTA )   Bipolar disorder Continue Risperdal
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cardiomyopathy, Chronic kidney disease, Computerised tomogram head normal, Condition aggravated
Clinical narrative: PROGRESS NOTE 2/06/2022 38 y.o. female with no significant past cardiac history, history of hypertension, depression and chronic kidney disease.  Patient was admitted with COVID-19 infection on 1/19/2022.  Her blood pressure was markedly elevated at 220/145.  Troponin level was increased.  Echocardiogram showed reduced left ventricular systolic function with wall motion abnormality.   Reason for cardiology follow-up is newly diagnosed cardiomyopathy, wall motion abnormality and elevated troponin.   Subjective: No new symptoms   Objective:  Blood pressure 126/87, pulse 85, temperature (!) 95.7 °F (35.4 °C), resp. rate 19, height 5' 1.5" (1.562 m), weight 80 kg (176 lb 5.9 oz), SpO2 99 %, not currently breastfeeding. General: comfortable, in no acute distress.   PLAN: Hypertensive emergency H/o noncompliance. Last se een by nephrology on an outpatient HTN/ chronic kidney disease in 12/2021.  They suspect that the etiology of her chronic kidney disease could be related to hypertensive nephrosclerosis and she did have some mild proteinuria.  Given her young age, they recommended work-up and follow-up for secondary causes  Resume Coreg 25 mg p.o. twice daily, chlorthalidone 25 mg p.o. daily, hydralazine 25 mg p.o. 3 times daily, and lisinopril 40 mg p.o. daily, Held BP meds in 2/4 BP on lower side.  Held lisinopril ( Cr bumped) , Restarted Coreg 2/5 , Hydralazine PRN  24-hour urine for catecholamines and metanephrines pending Renal artery ultrasound unremarkable      Acute LLE weakness / pain  R/o CVA ,decreased motor and sensation LLE  unknown onset  Discuss with Neurology seen  MRI / MRA w./o Cer w negative  Admit CT head no acute finding  US BLE r/o  DVT  PT/ OT , nurse report patient was able to ambulate to bathroom today    Elevated troponin Likely acute myocardial injury/strain from hypertensive emergency.   Echo mildly decreased, estimated LVEF 45-50%.Inferolateral and anterolateral hypokinesis. Aspirin, Coreg.  LDL 88 ( 3/18/20)  Consulted Cardiology  ?Coronary angiogram ( Cr 1.9 )      CKD stage III  Suspected due to hypertension  Last seen by Nephrology 12/21  Cr 1.5- 1.7 for the last few years  Admit Cr 1.68 -- > Cr 1.93  Avoid nephrotoxic meds       COVID-19 Multiple constitutional symptoms  Not on O2 currently  no indication for steroids Ddimer 5.34 , US LE negative.  heparin  Supportive cares    History of seizure disorder Continue Trileptal 300mgBIDPTA ( on 600mg BID  PTA )   Bipolar disorder Continue Risperdal
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Echocardiogram abnormal, Fibrin D dimer, Hypertension, Hypertensive emergency, Hypokinesia
Clinical narrative: PROGRESS NOTE 2/06/2022 38 y.o. female with no significant past cardiac history, history of hypertension, depression and chronic kidney disease.  Patient was admitted with COVID-19 infection on 1/19/2022.  Her blood pressure was markedly elevated at 220/145.  Troponin level was increased.  Echocardiogram showed reduced left ventricular systolic function with wall motion abnormality.   Reason for cardiology follow-up is newly diagnosed cardiomyopathy, wall motion abnormality and elevated troponin.   Subjective: No new symptoms   Objective:  Blood pressure 126/87, pulse 85, temperature (!) 95.7 °F (35.4 °C), resp. rate 19, height 5' 1.5" (1.562 m), weight 80 kg (176 lb 5.9 oz), SpO2 99 %, not currently breastfeeding. General: comfortable, in no acute distress.   PLAN: Hypertensive emergency H/o noncompliance. Last se een by nephrology on an outpatient HTN/ chronic kidney disease in 12/2021.  They suspect that the etiology of her chronic kidney disease could be related to hypertensive nephrosclerosis and she did have some mild proteinuria.  Given her young age, they recommended work-up and follow-up for secondary causes  Resume Coreg 25 mg p.o. twice daily, chlorthalidone 25 mg p.o. daily, hydralazine 25 mg p.o. 3 times daily, and lisinopril 40 mg p.o. daily, Held BP meds in 2/4 BP on lower side.  Held lisinopril ( Cr bumped) , Restarted Coreg 2/5 , Hydralazine PRN  24-hour urine for catecholamines and metanephrines pending Renal artery ultrasound unremarkable      Acute LLE weakness / pain  R/o CVA ,decreased motor and sensation LLE  unknown onset  Discuss with Neurology seen  MRI / MRA w./o Cer w negative  Admit CT head no acute finding  US BLE r/o  DVT  PT/ OT , nurse report patient was able to ambulate to bathroom today    Elevated troponin Likely acute myocardial injury/strain from hypertensive emergency.   Echo mildly decreased, estimated LVEF 45-50%.Inferolateral and anterolateral hypokinesis. Aspirin, Coreg.  LDL 88 ( 3/18/20)  Consulted Cardiology  ?Coronary angiogram ( Cr 1.9 )      CKD stage III  Suspected due to hypertension  Last seen by Nephrology 12/21  Cr 1.5- 1.7 for the last few years  Admit Cr 1.68 -- > Cr 1.93  Avoid nephrotoxic meds       COVID-19 Multiple constitutional symptoms  Not on O2 currently  no indication for steroids Ddimer 5.34 , US LE negative.  heparin  Supportive cares    History of seizure disorder Continue Trileptal 300mgBIDPTA ( on 600mg BID  PTA )   Bipolar disorder Continue Risperdal
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Left ventricular dysfunction, Low density lipoprotein increased, Magnetic resonance imaging normal, Motor dysfunction, Muscular weakness
Clinical narrative: PROGRESS NOTE 2/06/2022 38 y.o. female with no significant past cardiac history, history of hypertension, depression and chronic kidney disease.  Patient was admitted with COVID-19 infection on 1/19/2022.  Her blood pressure was markedly elevated at 220/145.  Troponin level was increased.  Echocardiogram showed reduced left ventricular systolic function with wall motion abnormality.   Reason for cardiology follow-up is newly diagnosed cardiomyopathy, wall motion abnormality and elevated troponin.   Subjective: No new symptoms   Objective:  Blood pressure 126/87, pulse 85, temperature (!) 95.7 °F (35.4 °C), resp. rate 19, height 5' 1.5" (1.562 m), weight 80 kg (176 lb 5.9 oz), SpO2 99 %, not currently breastfeeding. General: comfortable, in no acute distress.   PLAN: Hypertensive emergency H/o noncompliance. Last se een by nephrology on an outpatient HTN/ chronic kidney disease in 12/2021.  They suspect that the etiology of her chronic kidney disease could be related to hypertensive nephrosclerosis and she did have some mild proteinuria.  Given her young age, they recommended work-up and follow-up for secondary causes  Resume Coreg 25 mg p.o. twice daily, chlorthalidone 25 mg p.o. daily, hydralazine 25 mg p.o. 3 times daily, and lisinopril 40 mg p.o. daily, Held BP meds in 2/4 BP on lower side.  Held lisinopril ( Cr bumped) , Restarted Coreg 2/5 , Hydralazine PRN  24-hour urine for catecholamines and metanephrines pending Renal artery ultrasound unremarkable      Acute LLE weakness / pain  R/o CVA ,decreased motor and sensation LLE  unknown onset  Discuss with Neurology seen  MRI / MRA w./o Cer w negative  Admit CT head no acute finding  US BLE r/o  DVT  PT/ OT , nurse report patient was able to ambulate to bathroom today    Elevated troponin Likely acute myocardial injury/strain from hypertensive emergency.   Echo mildly decreased, estimated LVEF 45-50%.Inferolateral and anterolateral hypokinesis. Aspirin, Coreg.  LDL 88 ( 3/18/20)  Consulted Cardiology  ?Coronary angiogram ( Cr 1.9 )      CKD stage III  Suspected due to hypertension  Last seen by Nephrology 12/21  Cr 1.5- 1.7 for the last few years  Admit Cr 1.68 -- > Cr 1.93  Avoid nephrotoxic meds       COVID-19 Multiple constitutional symptoms  Not on O2 currently  no indication for steroids Ddimer 5.34 , US LE negative.  heparin  Supportive cares    History of seizure disorder Continue Trileptal 300mgBIDPTA ( on 600mg BID  PTA )   Bipolar disorder Continue Risperdal
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Myocardial injury, Nephrosclerosis, Pain in extremity, Proteinuria, Sensory loss
Clinical narrative: PROGRESS NOTE 2/06/2022 38 y.o. female with no significant past cardiac history, history of hypertension, depression and chronic kidney disease.  Patient was admitted with COVID-19 infection on 1/19/2022.  Her blood pressure was markedly elevated at 220/145.  Troponin level was increased.  Echocardiogram showed reduced left ventricular systolic function with wall motion abnormality.   Reason for cardiology follow-up is newly diagnosed cardiomyopathy, wall motion abnormality and elevated troponin.   Subjective: No new symptoms   Objective:  Blood pressure 126/87, pulse 85, temperature (!) 95.7 °F (35.4 °C), resp. rate 19, height 5' 1.5" (1.562 m), weight 80 kg (176 lb 5.9 oz), SpO2 99 %, not currently breastfeeding. General: comfortable, in no acute distress.   PLAN: Hypertensive emergency H/o noncompliance. Last se een by nephrology on an outpatient HTN/ chronic kidney disease in 12/2021.  They suspect that the etiology of her chronic kidney disease could be related to hypertensive nephrosclerosis and she did have some mild proteinuria.  Given her young age, they recommended work-up and follow-up for secondary causes  Resume Coreg 25 mg p.o. twice daily, chlorthalidone 25 mg p.o. daily, hydralazine 25 mg p.o. 3 times daily, and lisinopril 40 mg p.o. daily, Held BP meds in 2/4 BP on lower side.  Held lisinopril ( Cr bumped) , Restarted Coreg 2/5 , Hydralazine PRN  24-hour urine for catecholamines and metanephrines pending Renal artery ultrasound unremarkable      Acute LLE weakness / pain  R/o CVA ,decreased motor and sensation LLE  unknown onset  Discuss with Neurology seen  MRI / MRA w./o Cer w negative  Admit CT head no acute finding  US BLE r/o  DVT  PT/ OT , nurse report patient was able to ambulate to bathroom today    Elevated troponin Likely acute myocardial injury/strain from hypertensive emergency.   Echo mildly decreased, estimated LVEF 45-50%.Inferolateral and anterolateral hypokinesis. Aspirin, Coreg.  LDL 88 ( 3/18/20)  Consulted Cardiology  ?Coronary angiogram ( Cr 1.9 )      CKD stage III  Suspected due to hypertension  Last seen by Nephrology 12/21  Cr 1.5- 1.7 for the last few years  Admit Cr 1.68 -- > Cr 1.93  Avoid nephrotoxic meds       COVID-19 Multiple constitutional symptoms  Not on O2 currently  no indication for steroids Ddimer 5.34 , US LE negative.  heparin  Supportive cares    History of seizure disorder Continue Trileptal 300mgBIDPTA ( on 600mg BID  PTA )   Bipolar disorder Continue Risperdal
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Troponin increased, Ultrasound Doppler normal, Ultrasound kidney normal
Clinical narrative: PROGRESS NOTE 2/06/2022 38 y.o. female with no significant past cardiac history, history of hypertension, depression and chronic kidney disease.  Patient was admitted with COVID-19 infection on 1/19/2022.  Her blood pressure was markedly elevated at 220/145.  Troponin level was increased.  Echocardiogram showed reduced left ventricular systolic function with wall motion abnormality.   Reason for cardiology follow-up is newly diagnosed cardiomyopathy, wall motion abnormality and elevated troponin.   Subjective: No new symptoms   Objective:  Blood pressure 126/87, pulse 85, temperature (!) 95.7 °F (35.4 °C), resp. rate 19, height 5' 1.5" (1.562 m), weight 80 kg (176 lb 5.9 oz), SpO2 99 %, not currently breastfeeding. General: comfortable, in no acute distress.   PLAN: Hypertensive emergency H/o noncompliance. Last se een by nephrology on an outpatient HTN/ chronic kidney disease in 12/2021.  They suspect that the etiology of her chronic kidney disease could be related to hypertensive nephrosclerosis and she did have some mild proteinuria.  Given her young age, they recommended work-up and follow-up for secondary causes  Resume Coreg 25 mg p.o. twice daily, chlorthalidone 25 mg p.o. daily, hydralazine 25 mg p.o. 3 times daily, and lisinopril 40 mg p.o. daily, Held BP meds in 2/4 BP on lower side.  Held lisinopril ( Cr bumped) , Restarted Coreg 2/5 , Hydralazine PRN  24-hour urine for catecholamines and metanephrines pending Renal artery ultrasound unremarkable      Acute LLE weakness / pain  R/o CVA ,decreased motor and sensation LLE  unknown onset  Discuss with Neurology seen  MRI / MRA w./o Cer w negative  Admit CT head no acute finding  US BLE r/o  DVT  PT/ OT , nurse report patient was able to ambulate to bathroom today    Elevated troponin Likely acute myocardial injury/strain from hypertensive emergency.   Echo mildly decreased, estimated LVEF 45-50%.Inferolateral and anterolateral hypokinesis. Aspirin, Coreg.  LDL 88 ( 3/18/20)  Consulted Cardiology  ?Coronary angiogram ( Cr 1.9 )      CKD stage III  Suspected due to hypertension  Last seen by Nephrology 12/21  Cr 1.5- 1.7 for the last few years  Admit Cr 1.68 -- > Cr 1.93  Avoid nephrotoxic meds       COVID-19 Multiple constitutional symptoms  Not on O2 currently  no indication for steroids Ddimer 5.34 , US LE negative.  heparin  Supportive cares    History of seizure disorder Continue Trileptal 300mgBIDPTA ( on 600mg BID  PTA )   Bipolar disorder Continue Risperdal
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Blood creatine phosphokinase increased, COVID-19, Condition aggravated, Fall
Clinical narrative: Patient was hospitalized due to recurrent mechanical fall sec to generalized weakness with COVID-19 infection, and rhabdomyolysis, without respiratory symptoms. Infection was treated with vitamin-C/vitamin-D/zinc.  He was started on IV hydration. 7 days after hospitalization he was transferred into rehab for an additional 7 days.n
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Rhabdomyolysis, SARS-CoV-2 test positive
Clinical narrative: Patient was hospitalized due to recurrent mechanical fall sec to generalized weakness with COVID-19 infection, and rhabdomyolysis, without respiratory symptoms. Infection was treated with vitamin-C/vitamin-D/zinc.  He was started on IV hydration. 7 days after hospitalization he was transferred into rehab for an additional 7 days.n
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: ADMITTED TO HOSPITAL
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Admitted to hospital with positive COVID 2/5/22
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: ADMITTED TO HOSPITAL